Evidence map›Paper›PMID 10940146›Full record

SynthesisJournal of general internal medicine2000

Revisiting the oral glucose tolerance test criterion for the diagnosis of diabetes.

M B Davidson, D L Schriger, A L Peters, B Lorber

Open access · bronzeAbstract readMeta-Analysis
In one paragraph

Synthesis in Journal of general internal medicine, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Significance of HbA1c and its measurement in the diagnosis of diabetes mellitus: US experience.Diabetes, metabolic syndrome and obesity : targets and therapy · 2014
    Review
  7. Article
  8. An Innovative Mathematical Model: A Key to the Riddle of HbA(1c).International journal of endocrinology · 2010
    Article
  9. Article
  10. Article
  11. Hemoglobin A1c concentrations and risk of colorectal cancer in women.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2005
    Article
  12. Article
  13. Diagnosing diabetes. A practitioner's plea: keep it simple.Journal of general internal medicine · 2000
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

M B DavidsonCharles R. Drew University of Medicine and Science, Los Angeles, Calif, USA. mdavids@cdrewu.edu
D L Schriger
A L Peters
B Lorber
University of California, Los Angeles · USCharles R. Drew University of Medicine and Science · US

Funding

CLINICAL TRIALS UNITU01DK054047 · NIDDK · CHARLES R. DREW UNIVERSITY OF MED &SCI · PI DAVIDSON, MAYER BENSON · 1997 to 2003
$5.1M
NIDDK NIH HHS 5U01 DK54047
6 · The paper itself

Abstract

objectiveThe Expert Committee on the Diagnosis and Classification of Diabetes retained the 2-hour glucose concentration on an oral glucose tolerance test of >/=11.1 mmol/L (200 mg/dL) as a criterion to diagnose diabetes. Since glycated hemoglobin levels have emerged as the best measure of long-term glycemia and an important predictor of microvascular and neuropathic complications, we evaluated the distribution of hemoglobin A1C (Hb A1C) levels in individuals who had undergone an oral glucose tolerance test to determine how well 2-hour values could identify those with normal versus increased Hb A1C levels.

designA cross-sectional analysis of 2 large data sets was performed. We cross-tabulated 2-hour glucose concentrations on an oral glucose tolerance test separated into 4 intervals (<7.8 mmol/L [140 mg/dL], 7.8-11.0 mmol/L [140-199 mg/dL], 11.1-13.3 mmol/L [200-239 mg/dL], and >/=13.3 mmol/L [240 mg/dL]) with Hb A1C levels separated into 3 intervals (normal; <1% above the upper limit of normal; and greater than or equal to the upper limit of normal + 1%).

resultsApproximately two thirds of patients in both data sets with 2-hour glucose concentrations of 11.1 to 13.3 mmol/L (200-239 mg/dL) had normal Hb A1C levels. In contrast, 60% to 80% of patients in both data sets with 2-hour glucose concentrations >/=13.3 mmol/L (240 mg/dL) had elevated Hb A1C levels.

conclusionSince Hb A1C levels are the best measures presently available that reflect long-term glycemia, we conclude that the 2-hour glucose concentration criterion on an oral glucose tolerance test for the diagnosis of diabetes should be raised from >/= 11.1 mmol/L (200 mg/dL) to >/= 13.3 mmol/L (240 mg/dL) to remain faithful to the concept that diagnostic concentrations of glucose should predict the subsequent development of specific diabetic complications (e.g., retinopathy).

Indexed as

Glucose Tolerance TestBlood GlucoseCross-Sectional StudiesDiabetes MellitusGlycated HemoglobinHumansPredictive Value of TestsReference ValuesBlood GlucoseGlycated Hemoglobin

Identifiers

PMID10940146
PMCPMC1495578
OpenAlexW2076453027

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.